The typical regimen involves administering both drugs in cycles. For instance, in the treatment of breast cancer, Epirubicin and Cyclophosphamide might be given intravenously every 2 to 3 weeks for a total of 4 to 6 cycles. The exact dosage and schedule can vary based on the patient’s specific condition and overall health.
